TY - JOUR
T1 - Unravelling the role of microneedles in drug delivery
T2 - Principle, perspectives, and practices
AU - Babu, Molakpogu Ravindra
AU - Vishwas, Sukriti
AU - Khursheed, Rubiya
AU - Harish, Vancha
AU - Sravani, Anne Boyina
AU - Khan, Farhan
AU - Alotaibi, Bader
AU - Binshaya, Abdulkarim
AU - Disouza, John
AU - Kumbhar, Popat S.
AU - Patravale, Vandana
AU - Gupta, Gaurav
AU - Loebenberg, Raimar
AU - Arshad, Mohammed Faiz
AU - Patel, Archita
AU - Patel, Samir
AU - Dua, Kamal
AU - Singh, Sachin Kumar
N1 - Publisher Copyright:
© Controlled Release Society 2023.
PY - 2024/6
Y1 - 2024/6
N2 - In recent year, the research of transdermal drug delivery systems has got substantial attention towards the development of microneedles (MNs). This shift has occurred due to multifaceted advantages of MNs as they can be utilized to deliver the drug deeper to the skin with minimal invasion, offer successful delivery of drugs and biomolecules that are susceptible to degradation in gastrointestinal tract (GIT), act as biosensors, and help in monitoring the level of biomarkers in the body. These can be fabricated into different types based on their applications as well as material for fabrication. Some of their types include solid MNs, hollow MNs, coated MNs, hydrogel forming MNs, and dissolving MNs. These MNs deliver the therapeutics via microchannels deeper into the skin. The coated and hollow MNs have been found successful. However, they suffer from poor drug loading and blocking of pores. In contrast, dissolving MNs offer high drug loading. These MNs have also been utilized to deliver vaccines and biologicals. They have also been used in cosmetics. The current review covers the different types of MNs, materials used in their fabrication, properties of MNs, and various case studies related to their role in delivering therapeutics, monitoring level of biomarkers/hormones in body such as insulin. Various patents and clinical trials related to MNs are also covered. Covered are the major bottlenecks associated with their clinical translation and potential future perspectives. Graphical Abstract: (Figure presented.)
AB - In recent year, the research of transdermal drug delivery systems has got substantial attention towards the development of microneedles (MNs). This shift has occurred due to multifaceted advantages of MNs as they can be utilized to deliver the drug deeper to the skin with minimal invasion, offer successful delivery of drugs and biomolecules that are susceptible to degradation in gastrointestinal tract (GIT), act as biosensors, and help in monitoring the level of biomarkers in the body. These can be fabricated into different types based on their applications as well as material for fabrication. Some of their types include solid MNs, hollow MNs, coated MNs, hydrogel forming MNs, and dissolving MNs. These MNs deliver the therapeutics via microchannels deeper into the skin. The coated and hollow MNs have been found successful. However, they suffer from poor drug loading and blocking of pores. In contrast, dissolving MNs offer high drug loading. These MNs have also been utilized to deliver vaccines and biologicals. They have also been used in cosmetics. The current review covers the different types of MNs, materials used in their fabrication, properties of MNs, and various case studies related to their role in delivering therapeutics, monitoring level of biomarkers/hormones in body such as insulin. Various patents and clinical trials related to MNs are also covered. Covered are the major bottlenecks associated with their clinical translation and potential future perspectives. Graphical Abstract: (Figure presented.)
KW - Biosensors
KW - Cancer
KW - Diabetes
KW - Materials of fabrication
KW - Microneedles
KW - Rheumatoid arthritis
KW - Transdermal drug delivery
UR - http://www.scopus.com/inward/record.url?scp=85178213051&partnerID=8YFLogxK
U2 - 10.1007/s13346-023-01475-9
DO - 10.1007/s13346-023-01475-9
M3 - Review article
C2 - 38036849
AN - SCOPUS:85178213051
SN - 2190-393X
VL - 14
SP - 1393
EP - 1431
JO - Drug Delivery and Translational Research
JF - Drug Delivery and Translational Research
IS - 6
ER -